Inicio>>Signaling Pathways>> Antibody-drug Conjugate/ADC Related>> ADC Cytotoxin>>MMAF sodium

MMAF sodium (Synonyms: Monomethylauristatin F sodium)

Catalog No.GC38397

El MMAF sÓdico (monometilauristatina F sÓdica) es un potente inhibidor de la polimerizaciÓn de la tubulina y se utiliza como agente antitumoral. El MMAF sÓdico (Monometilauristatina F sÓdica) se usa ampliamente como componente citotÓxico de conjugados de anticuerpo-fÁrmaco (ADC) como Vorsetuzumab mafodotina y SGN-CD19A.

Products are for research use only. Not for human use. We do not sell to patients.

MMAF sodium Chemical Structure

Cas No.: 1799706-65-2

Tamaño Precio Disponibilidad Cantidad
5mg
72,00 $
Disponible
10mg
108,00 $
Disponible
25mg
162,00 $
Disponible
50mg
225,00 $
Disponible
100mg
306,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

MMAF sodium (Monomethylauristatin F sodium) is a potent tubulin polymerization inhibitor and is used as a antitumor agent. MMAF sodium (Monomethylauristatin F sodium) is widely used as a cytotoxic component of antibody-drug conjugates (ADCs) such as Vorsetuzumab mafodotin and SGN-CD19A[1][2][3].

MMAF inhibits anaplastic large cell lymphoma Karpas 299, breast carcinoma H3396, renal cell carcinoma 786-O and Caki-1 cells with IC50s of 119, 105, 257 and 200 nM in vitro cytotoxicity assay[4].

[1]. Lee JW, et al. EphA2 targeted chemotherapy using an antibody drug conjugate in endometrial carcinoma. Clin Cancer Res. 2010 May 1;16(9):2562-70. [2]. Lee JJ, et al. Enzymatic prenylation and oxime ligation for the synthesis of stable and homogeneous protein-drug conjugates for targeted therapy. Angew Chem Int Ed Engl. 2015 Oct 5;54(41):12020-4. [3]. Kim EG, et al. Strategies and Advancement in Antibody-Drug Conjugate Optimization for Targeted CancerTherapeutics. [4]. Doronina SO, et al. Enhanced activity of monomethylauristatin F through monoclonal antibody delivery: effects of linker technology on efficacy and toxicity. Bioconjug Chem. 2006 Jan-Feb;17(1):114-24.

Reseñas

Review for MMAF sodium

Average Rating: 5 ★★★★★ (Based on Reviews and 26 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for MMAF sodium

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.